Mild hyperhomocysteinemia promotes renal hemodynamic dysfunction without histopathologic changes in adult rats.
In the normal kidney, nitric oxide plays a key role in the homeostatic regulation of vascular, glomerular, and tubular function maintaining normal renal perfusion, glomerular filtration rate (GFR), and renal vascular resistance (RVR) [1, 2] .
Increased superoxide anion radical (•O 2 − ) production inactivates the release of nitric oxide and reduces its bioavailability by peroxynitrite (OONO − ) formation. Thus, a greater nitric oxide inactivation may reduce medullar blood flow, contributing to the development of renal failure [3] .
Homocysteine is a thiol-containing amino acid. Homocysteine goes through the trans-sulphuration pathway which requires vitamin B 6 as a cofactor to produce cystathionine, cysteine, and glutathione or is methylated to methionine taking a methyl group from choline-derived betaine (betaine methyl transferase) or 5-methyl-tetrahydrofolic acid (methionine sintetase, which needs vitamin B 12 as a cofactor) ( Fig. 1) [4, 5] .
Different studies have shown that hyperhomocysteinemia is associated with increased risk of vascular disease involving coronary, cerebral, and peripheral arteries [6, 7] . Depending on the definition of hyperhomocysteinemia, 10% to 20% of the general population, more than 85% of patients with end-stage kidney disease (ESRD) [8, 9] and up to 32% of the individuals having premature peripheral arterial disease [10] have increased homocysteine levels. On the other hand, hyperhomocysteinemia is a frequent finding in heart, liver, and renal transplant recipients and is associated with renal dysfunction, even though the etiologic factors have not been clearly identified [11] [12] [13] .
We recently studied the impact of increased level of homocysteine on renal function showing that hyperhomocysteinemia induces renal oxidative stress and renal hemodynamic dysfunction involving altered L-arg-nitric oxide pathway [14] . In addition, it has been found that hyperhomocysteinemia is also able to promote glomerular damage [15] or generate tubulointerstitial lesions [16] . However, these morphologic findings were reported in rats with unilateral nephrectomy or in weanling rats, two experimental models that are exposed to other concomitant vascular risk factors. Therefore, the aim of this work is to study whether mild hyperhomocisteinemia per se can induce renal histopathologic changes in adult Wistar rats with normal renal function at either 10 or 44 weeks of treatment.
METHODS

Animals
Two-month-old male Wistar rats (N = 52) (180 to 220 g) were used. The animals were maintained on a standard rat chow (Argentine Cooperative Association, Animal Nutritional Division) and tap water. They were housed under a 12/12-hour day/night cycle at a steady temperature of 25
• C. After 1 week of acclimatization, they were randomly allocated to either a normal control (N = 26) or hyperhomocysteinemic (N = 26) group. Control and hyperhomocysteinemic groups had free access during 10 or 44 weeks to either tap water or homocysteine thiolactone (HTL) (50 mg/kg/day), respectively [17] .
Plasma homocysteine levels
Femoral arterial blood samples (200 lL) were withdrawn at baseline, 10 or 44 weeks and immediately cooled in Eppendorff tubes containing 0.1% ethylenediaminetetraacetic acid (EDTA). Plasma was separated by centrifugation at 4
• C and immediately frozen at −60 • C until the day of analysis. Total plasma homocysteine levels were determined using the Bio-Rad high-performance liquid chromatography (HPLC) kit (Bio-Rad, Hercules, CA, USA) [18] .
Renal hemodynamic function determination
Hemodynamic studies were performed in conscious unrestrained rats as previously described [19] . Briefly, at 10 and 44 weeks, 6 animals of each group (control and hyperhomocysteinemic) were anesthetized to cannulate both the femoral artery and the femoral vein. After recovery from surgery and in euvolemic conditions, a priming dose of inulin (16 mg/kg) and sodium para-aminohippurate (PAH) (8 mg/kg) were administered. Immediately after, a continuous intravenous infusion of 0.9% NaCl containing inulin (36 mg/mL) and PAH (11.6 mg/mL) was given at a rate of 0.0267 mL/min. After a 105-minute equilibration period, baseline arterial blood samples were taken.
Blood samples were used for hematocrit, inulin, and PAH determinations. Clearances of inulin (GFR) and PAH [renal plasma flow (RPF)] were calculated as previously described [20, 21] . RVR were calculated from mean arterial pressure (MAP) and renal blood flow (RBF) according to: RVR = MAP/RBF (mm Hg × min × 100 g body weight/mL); RBF = RPF/(1-hematocrit/100) (mL/min × 100 g body weight) [22] .
Blood pressure and heart rate were monitored throughout the study via an arterial catheter connected to a Statham pressure transducer (Gould Instrument, Cleveland, OH, USA) and attached to a polygraph recorder (model 2400S) (Gould Instrument). 
Histopathologic examination
Kidneys of 28 rats (Table 1) were fixed by perfusion [23] with 4% paraformaldehyde in 0.135 mol/L phosphate buffer, embedded in paraffin, and sections were stained with hematoxylin-eosin, periodic acid-Schiff (PAS), Masson's trichrome, and Gallego (elastic fibers) following standard methods [24] for histopathologic and morphometric studies.
The presence of myofibroblasts was evaluated with immunomarcation against a-smooth muscle actin (a-SMA) (Sigma Chemical Co., St. Louis, MO, USA).
Glomerular measurements (Image Pro Plus program) were taken in each left kidney in 50 subcapsular, medium and yuxtamedullary glomeruli, in PAS-stained sections. Mesangial expansion and glomerular sclerosis were evaluated following the method of Raij et al [25] , whereas interstitial fibrosis was estimated according to the method of Shih et al [26] .
All these assessments were carried out under blind conditions.
Chemicals and reagents
Ether (Sigma Chemical Co.) and ketamine (G & M.S.A., Buenos Aires, Argentina) were used as anaesthetics. HTL were purchased from Sigma Chemical Co. Sterile and nonpyrogenic inulin (Cypros Pharmaceutical Co., West Carlsbad, CA, USA), and PAH ampules for intravenous administration (Merck & Co., Inc., West Point, PA, USA) were used.
Statistical analysis
All values are expressed as mean ± SD. Comparisons between hyperhomocysteinemic and control groups at 10 and 44 weeks were done by one-way analysis of variance (ANOVA) followed by the Newman-Keuls as post hoc test. Differences between values were considered to be statistically significant when P < 0.05.
RESULTS
No significant differences were found in either body weight, fluid, or food consumption between hyperhomocysteinemic and control groups at 10 and 44 weeks.
Plasma homocysteine levels
Basal plasma homocysteine concentration did not differ between the two groups. After HTL administration, total plasma homocysteine levels were 53% (10 weeks) and 56% (44 weeks) higher in hyperhomocysteinemic group compared to the control group (8.11 ± 1.5 and 8.27 ± 1.6 lmol/L vs. 5.3 ± 0.8 lmol/L, respectively, P < 0.001).
Renal hemodynamic function determination
Under baseline conditions, MAP and RVR were significantly higher in the hyperhomocysteinemic group than in controls ( Fig. 2A and D) . Conversely, GFR (Fig. 2B) and RPF (Fig. 2C) were significantly lower in the hyperhomocysteinemic than in the control group.
Histopathologic evaluation
The histopathologic studies did not show any differences between the control and hyperhomocysteinemic rats at either 10 or 44 weeks (Figs. 3 and 4) .
The results of the morphometric evaluations are indicated in Table 1 . The glomerular area did not show differences among the different groups.
There was only a minimal increase in the amount of mesangial matrix in some glomeruli, but there was no evidence of glomerulosclerosis. There was interstitial fibrosis in just one hyperhomocysteinemic rat.
Immunomarcation against a-SMA did not show any difference among groups.
No renal vascular changes were observed either in the hyperhomocysteinemic or in the control rats.
DISCUSSION
The present study examined chronic effects of mild hyperhomocysteinemia on renal function and morphology in Wistar adults rats whose plasma homocysteine levels were increased by water supplementation of homocysteine thiolactone (50 mg/kg/day). Despite the fact that mild hyperhomocysteinemia induces renal functional and biochemical alterations and increases systemic blood pressure, they are not associated with renal morphologic changes as evaluated by light microscopy at 10 or at 44 weeks of treatment. Homocysteine is formed by the demethylation of methionine. Increased plasma homocysteine levels can occur as a genetic disease or as a consequence of a nutritional deficiency in those factors that promote homocysteine metabolism such as folic acid, vitamin B 12 , vitamin B 6 , and betaine (Fig. 1) [4, 5, [27] [28] [29] . Another major acquired cause of increased homocysteine values is chronic renal failure [30] . Homocysteine-induced oxidant injury of vascular endothelium has been proposed as a more contributing mechanism linking hyperhomocysteinemia to vascular disease. Numerous studies have suggested that the increased oxidative stress promoted by hyperhomocysteinemia is able to reduce nitric oxide bioavailability [31] , increase vascular tone [32] , and alter elastic properties of the vascular wall [33] . By this way, hyperhomocysteinemia is an important risk factor for cardiovascular disease development.
Recent investigations suggest that oxygen radicals may contribute to enhanced renal vascular tone, increased sensitivity to vasoconstrictors and impaired renal endothelium vasodilatation [34] [35] [36] . Hyperhomocysteinemia promotes the reaction between increased level of superoxide anion and nitric oxide, inducing peroxynitrite formation which, in turn, can nitrosylate membrane proteins and oxidized arachidonic acid, releasing F2-isoprostanes. These are potent renal vasoconstrictors, leading to a fall in glomerular capillary pressure and causing a marked reduction of GFR and RBF [37] [38] [39] . This related linear increase of F2-isoprostanes, at elevated plasma homocysteine levels [40] might be involved on homocysteine-induced renal deleterious function [14, 15] and could be an important pathogenic factor in glomerular damage associated with hypertension [41] .
Structural alterations due to hyperhomocysteinemia have also been previously reported [16, 41] . Li et al [41] used uninephrectomized male Sprague-Dawley rats which, after 1 week recovery of the surgery, received methionine (1 g/kg per day for 6 weeks, orally). At the end of the experiment, homocysteine levels ( ∼ =12 lmol/L vs. 6 lmol/L) as well as proteinuria ( ∼ =60 mg/24 hours vs. ∼ =30 mg/24 hours) were higher in these treated rats. In addition, hyperhomocysteinemic rats showed increased glomerular extracellular matrix and expanded the glomerular mesangium with hypercellularity, capillary collapse, and fibrous deposition in the glomeruli. The glomerular injury score was higher than in control rats (3 vs. 1). In the same paper the authors showed that hyperhomocysteinemia is able to induce proteinuria and glomerular sclerosis in Dahl-sensitive hypertensive rats exposed to high salt (4% NaCl) diet [41] .
Kumagai et al [16] studied the effects of folate deficiency, choline deficiency, and methionine loading on homocysteinemia, renal function, and renal histopathology on weanling male Fisher rats over a 12-week period. Folate deficiency, choline deficiency, and methionine loading (1.25% supplementation) synergistically induced hyperhomocysteinemia (up to 69.7 lmol/L) without any change in blood pressure. A negative correlation was found between creatinine clearance and homocysteinemia. The kidneys of hyperhomocysteinemic rats showed arterial and arteriolar wall thickening and focal tubulointerstitial fibrosis. The lesions of interstitial fibrosis appear wedge-shaped at the subcapsular cortex of the kidney; the expression of vascular endothelial growth factor was increased in the adjacent more intact area of the cortex. The authors suggest that the interstitial lesions could be mediated by severe ischemia due to regional circulatory disorder.
The more severe lesions were found in the hyperhomocysteinemic rats fed a choline and folate-deficient diet. In relation to this fact, it is interesting to point out that weanling rats fed a choline-deficient diet develop acute renal failure with lesions that vary from focal tubular necrosis to widespread cortical necrosis or the eventual presence of reparative changes [42] . Methionine has a protective effect in relation to the renal lesions induced by choline deficiency and 0.5 mg of methionine per gram of diet is enough to prevent the renal damage [43] . So, in the experiment of Kumagai et al [16] the renal lesions can not be ascribed to choline deficiency per se because the methionine concentration of the casein of the diet plus that added to the diet (1.2%) is enough to prevent the renal lesions.
Different hypothesis can be advanced to explain the controversy between our results and those of Li et al [41] and Kumagai et al [16] . It is known that even in the same rodent species, different susceptibilities to the same injury can be observed. By this way, the susceptibility to developing glomerulosclerosis varies in different strains of mice [44] and rats [45] . Therefore, the impact of hyperhomocysteinemia on renal morphology might differ related to the strain analyzed [Fisher (Kumagai), Sprague-Dawley (Li) or Wistar (this paper)].
Another factor that could be involved in the differences found may be the procedure employed to induce hyperhomocysteinemia as well as the final plasma levels of homocysteine reached. Li et al [41] induced hyperhomocysteinemia by adding methionine in the drinking water, Kumagai et al [16] added the methionine to the food; and we have induced the hyperhomocysteinemia by adding homocysteine thiolactone to the drinking water (50 mg/kg per day). In all the three works homocysteinemia was increased, 12, 69.7, and 8.2 lmol/L in the experiments of Li et al [41] , Kumagai et al [16] and this one, respectively, and renal injury related to homocysteine plasma concentration were observed, suggesting that no matter the procedure to induce hyperhomocysteinemia, the renal injury extent may depend on the reached homocysteine plasma level.
Another important consideration could be the variability of the renal response to different types of injury depending on the animal age or renal growth. Thus, while a choline-deficient diet is able to induce acute renal failure with tubular or cortical necrosis in weanling rats [42] , the same diet do not develops renal necrosis in adults unless it is submitted at the compensatory renal hypertrophy period after unilateral nephrectomy [46, 47] . In the same line, both in rats and human beings, the glomerular morphologic response to a diminished number of glomeruli induces more deleterious consequences when the loss of nephrons take place at an earlier period in life [48, 49] . With regard to this issue, Kumagai et al [16] highlighted that "our preliminary experiment with older rats failed to induce such severe renal injury, although the plasma homocysteine level of these rats reached the same level as that in the present study."
CONCLUSION
Our results show that in adult rats with normal kidney function, mild hyperhomocysteinemia induces renal hemodynamic dysfunction and increased systemic blood pressure. However, we have found no differences be-tween cells expressing a-SMA (myofibroblasts) in the glomeruli or in the renal interstitium from controls or hyperhomocysteinemic rats. The present cells have been proved to be a good predictor of renal disease progression both in experimental animal [50] and human studies [51] , supporting that no morphologic findings related to glomerular or interstitial sclerosis or fibrosis are induced by mild hyperhomocysteinemia if the animals are not exposed to other concomitant vascular risk factors. Taking into account that we have recently proved that antioxidant treatment may revert homocysteine-induced renal functional and biochemical deleterious effects, the present results may contribute to the treatment of incipient or moderate increments of homocysteine plasma levels before the development of structural alterations, preventing later vascular complications and reducing the cardiovascular risk.
